Showing results (81-90 of 3,386) with videos related to
Sort By:
Pageof 339
Carcinogenesis|October 1, 1988
A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liverK Randerath, L J Lu, D LiCancer Research|May 15, 1987
Correlation of aromatic hydroxylation of 11 beta-substituted estrogens with morphological transformation in vitro but not with in vivo tumor induction by these hormonesJ G Liehr, R H Purdy, J S Baran, et al.Carcinogenesis|March 1, 1989
Reduced accumulation of I-compounds in liver DNA of rats fed a choline-devoid dietD Li, N Chandar, B Lombardi, et al.Carcinogenesis|July 1, 1992
Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNAD Li, B Moorthy, S Chen, et al.Carcinogenesis|May 1, 1993
3-Methylcholanthrene-inducible liver cytochrome(s) P450 in female Sprague-Dawley rats: possible link between P450 turnover and formation of DNA adducts and I-compoundsB Moorthy, S Chen, D Li, et al.Carcinogenesis|December 1, 1991
Specific reduction of I-compound levels in DNA from spontaneous hepatomas of 22-24 month old male C3H miceD Li, S Chen, F F Becker, et al.Mutation Research|October 1, 1995
DNA adducts induced by lipids and lipid peroxidation products: possible relationships to I-compoundsD Li, M Wang, J G Liehr, et al.The Journal of Biological Chemistry|July 17, 2001
A 32P-postlabeling assay for the oxidative DNA lesion 8,5'-cyclo-2'-deoxyadenosine in mammalian tissues: evidence that four type II I-compounds are dinucleotides containing the lesion in the 3' nucleotideK Randerath, G D Zhou, R L Somers, et al.Mutation Research|March 5, 1999
Endogenous formation and significance of 1,N2-propanodeoxyguanosine adductsF L Chung, R G Nath, M Nagao, et al.Toxicology|October 28, 1996
32P-postlabeling of 1,3-butadiene and 4-vinyl-1-cyclohexene metabolite-DNA adducts: in vitro and in vivo applicationsN Mabon, K RanderathPageof 339